✓ Luottokorttimaksut palautettu — turvallinen kassaprosessi Privacy Shieldin kautta

Xtane

✅ Lowers estrogen levels
✅ Reduces cancer growth
✅ Supports breast health
✅ Effective post-surgery
✅ Lowers recurrence risk

Xtane contains Exemestane.

Tuotekoodi: Ei saatavilla Kategoria: Avainsana: ,

Lääketieteellinen tarkistus Morgan Ellis — Farmasian tutkija · 8 vuoden kokemus  · Viimeisin arvio: toukokuu 2026

Osta enemmän, säästä enemmän Hinta per tabletti
30 tablettia
US$2.50/tablet
US$75.00
60 tablettia
US$2.47/tablet · säästä 1%
US$148.00
90 tablettia
US$2.36/tablet · säästä 6 %
US$212.00
180 tablettia
US$2.21/tablet · säästä 12%
US$398.00
360 Tablet/s
US$2.15/tablet · säästä 14 %
US$775.00
720 Tablet/s PARAS ARVO
US$2.04/tabletti · säästä 18%
US$1,470.00
Salattu kassavaihe
Kryptomaksut 10% halvempia
Hienovaraiset maailmanlaajuiset toimitukset
1 400+ asiakasta · 50+ maata

⚡ Quick Answer — What is Xtane?

Xtane is an oral tablet from Natco Pharma containing exemestane 25 mg — a third-generation steroidal aromatase inactivator. Adjuvant and metastatic therapy for hormone-receptor-positive breast cancer in postmenopausal women. Standard dose: 25 mg once daily after a meal, typically for 5–10 years in adjuvant setting. Exemestane irreversibly inactivates aromatase (suicide inhibitor) versus the reversible binding of anastrozole/letrozole. Often the AI of choice for sequential therapy after 2–3 years of tamoksifeeni (per IES trial), or after intolerance of a non-steroidal AI. Postmenopausal women only. Same bone-density and arthralgia issues as other AIs — mandatory DEXA monitoring + calcium/vitamin D + consider bisphosphonate.

Mitä saat MedsBasen kautta: WHO-GMP sertifioitu valmistaja · Hienotunteinen pakkaus · Maailmanlaajuinen toimitus · 1 400+ varmennettua asiakasarviota

📦 Jokainen tilaus on katettuna meidän Reshipment Assurance Policy -politiikkamme piiriin — jos lähetyksesi ei saavu 20 arkipäivässä, lähetämme uuden.

⚠ Erityislääkärin valvonta vaaditaan. Syöpälääkkeitä saa määrätä vain hoitava onkologi varmennetun diagnoosin, perustason levinneisyyden ja määritellyn hoitosuunnitelman perusteella. Älä koskaan aloita, lopeta, muuta annosta tai käytä syöpälääkettä onkologian hoitosuunnitelman ulkopuolella. Useimmat syöpälääkkeet vaativat säännöllistä verikokeiden seurantaa (FBC, LFT, munuaistoiminta), ovat ehdottomasti raskauden vastaisia ja niillä on merkittäviä lääkevuorovaikutuksia.
🔒 Salattu kassalle siirtyminen · 💳 Varmennettu maksunvälittäjä · 🚚 Maailmanlaajuinen toimitus · ⭐ 4,9/5 yli 1 400 asiakkaan arvostelusta

What Is Xtane?

Xtane is an oral tablet from Natco Pharma containing exemestane 25 mg. Exemestane is a third-generation, steroidal aromatase inactivator — structurally and mechanistically distinct from the non-steroidal aromatase inhibitors anastrozole and letrozole. It is used for adjuvant and metastatic treatment of hormone-receptor-positive (HR+) breast cancer in postmenopausal women. Originally developed by Pfizer (brand name Aromasin), exemestane is now a widely-used generic.

How Does Xtane Work?

Exemestane is a suicide substrate inhibitor (irreversible inactivator) of aromatase, the enzyme that converts androgens to oestrogens in postmenopausal peripheral tissue. Mechanistically:

  • Steroidal structure resembling the natural androgen substrate (androstenedione) — binds the aromatase active site and is then irreversibly converted to a covalent enzyme adduct that permanently inactivates the enzyme molecule.
  • Suppresses circulating oestrogen by ~95% within days — comparable to anastrozole and letrozole.
  • No cross-resistance with non-steroidal AIs — patients who progressed on anastrozole or letrozole sometimes respond to exemestane (and vice-versa) because the mechanism is structurally distinct.
  • Mild androgenic effect — exemestane and its main metabolite have weak androgen-receptor activity, which may slightly mitigate the bone-density loss seen with non-steroidal AIs (though clinical significance debated).

Käyttö ja indikaatiot

  • Adjuvanttihoidoissa for early HR+ breast cancer in postmenopausal women, typically as sequential therapy after 2–3 years of tamoksifeeni (per IES trial) or as primary AI
  • Metastatic HR+ breast cancer after progression on a non-steroidal AI (anastrozole or letrozole)
  • Combined with everolimus for HR+ HER2- metastatic breast cancer after non-steroidal AI failure (BOLERO-2)
  • Off-label: chemoprevention in high-risk postmenopausal women (MAP.3 trial); ovulation induction in PCOS (specialist)

Xtane is ei indicated for: premenopausal women without ovarian suppression, HR-negative breast cancer, or non-cancer cosmetic indications.

Xtane Dosage and How to Take

Vakioannos: 25 mg once daily after a meal. Food increases exemestane bioavailability by approximately 40% — so this is more than just a tolerability rule.

How to Take Xtane Properly

  1. Take one 25 mg tablet once daily after a meal. Food significantly increases absorption — do NOT take on an empty stomach.
  2. Same time each day for consistency.
  3. Nielaiset tabletit kokonaisena veden kanssa.
  4. Pakollinen seuranta: baseline DEXA bone-density scan, repeat every 2 years. Annual lipid panel.
  5. Bone protection: calcium 1,000–1,200 mg/day + vitamin D 800–2,000 IU/day. Bisphosphonate or denosumab if osteopenia develops.
  6. Joint pain management: regular exercise, paracetamol/NSAIDs as needed. Switching to anastrozole tai letrozole may help if exemestane arthralgia is intolerable.
  7. Hoidon kesto: 5 years total endocrine therapy (or longer in higher-risk disease) in adjuvant setting; until progression in metastatic.
  8. Älä keskeytä ilman onkologin ohjeita.

Side Effects of Xtane

Common (oestrogen-deprivation symptoms):

  • Hot flushes (35–40%)
  • Arthralgia and myalgia (~30%)
  • Vaginal dryness, dyspareunia
  • Mood changes, fatigue
  • Mild hair thinning
  • Increased sweating
  • Nausea (mild, usually settles)

Important long-term:

  • Accelerated bone-density loss and increased fracture risk — possibly slightly less than non-steroidal AIs (mild androgenic effect of exemestane), but clinical significance debated
  • Mild androgenic side effects (acne, hair changes) — uncommon but distinctive
  • Hyperlipidaemia (mild)

Less common but seek review:

  • Hepatotoxicity (mild LFT rises common)
  • Lymphocytopaenia, thrombocytopaenia
  • Severe hypersensitivity
  • Carpal tunnel syndrome

Varoitukset ja varotoimet

  • Pregnancy: ABSOLUTE CONTRAINDICATION. Exemestane is teratogenic. Postmenopausal patients usually past childbearing potential, but perimenopausal patients need reliable contraception.
  • Ennen menopausea olevat naiset: ineffective unless combined with ovarian suppression under specialist guidance.
  • Bone health: baseline DEXA, repeat every 2 years. Calcium + vitamin D + bisphosphonate/denosumab if osteopenia.
  • Hepatic and renal impairment: no dose adjustment for mild-moderate; caution in severe.
  • Concurrent oestrogen therapy: avoid — defeats the purpose.

Lääkeaineenvaihdunta

YhdistäVaikutusToimenpide
Voimakkaat CYP3A4-induktorit (rifampisiini, fenytoiini, karbamasepiini, miehenkuisma)Lower exemestane levels significantly — treatment failure riskAvoid combination. If CYP3A4 inducer is essential, double exemestane to 50 mg/day under specialist guidance.
Oestrogen-containing HRT or vaginal oestrogenDefeats mechanism — treatment failsAvoid. Use non-hormonal vaginal moisturisers.
TamoxifenTamoxifen reduces exemestane levelsUse sequentially, not concurrently.
Bisphosphonates / denosumabSynergistic bone protectionAdd when osteopenia develops.
Everolimus (mTOR inhibitor)Standard combination for metastatic HR+ HER2- breast cancer (BOLERO-2)Specialist oncology prescribing.

Säilytysohjeet

  • Säilytä huoneenlämmössä, 15–30°C. Säilytä alkuperäisessä puskarissa.
  • Säilytä lasten ja lemmikkien ulottumattomissa.
  • Palauta käyttämättömät tabletit apteekkiin hävitystä varten.

Aiheeseen liittyvät vaihtoehdot MedsBasessa

Muut tämän tuotteen rinnalla varastossa olevat syöpälääkkeet:

Selaa kaikkia syöpälääkkeitä →

Miksi tilata MedsBasesta

Jokainen erä on hankittu WHO-GMP sertifioitu valmistaja. Tilaukset toimitetaan yksinkertaisessa, brändittömässä pakkauksessa täyttöpartneriemme kautta ja niihin kuuluu Reshipment Assurance Policy -politiikkamme piiriin: jos lähetys ei saavu 20 arkipäivän kuluessa, lähetämme uuden ilmaiseksi, kysymättä lisäkysymyksiä.

Aiheeseen liittyvät syöpälääkkeet

Muut tämän tuotteen rinnalla varastossa olevat syöpälääkkeet:

Usein Kysytyt Kysymykset

Why must Xtane be taken with food?

Food increases exemestane bioavailability by approximately 40% — this is a true pharmacokinetic effect, not just a tolerability rule. Taking exemestane on an empty stomach significantly underdoses you. Take after the first major meal of the day for consistent absorption.

How is Xtane different from anastrozole and letrozole?

Exemestane is a steroidal aromatase inactivator that irreversibly destroys aromatase enzyme molecules. Anastrozole and letrozole are non-steroidal reversible inhibitors. The clinical implications: (1) no cross-resistance — patients who progress on anastrozole or letrozole may still respond to exemestane; (2) mild androgenic effect of exemestane (sometimes used to argue marginally lower bone-loss, though clinical significance debated); (3) different food-effect (exemestane absorption increases 40% with food).

When is Xtane preferred over anastrozole or letrozole?

Three common scenarios: (1) sequential therapy after 2–3 years of tamoxifen (the IES trial used exemestane in this setting); (2) after progression on anastrozole or letrozole — the structurally distinct mechanism may give renewed response; (3) after intolerable arthralgia on a non-steroidal AI — about 30% of patients tolerate one AI but not another.

How long do I take Xtane for?

Standard adjuvant duration is 5 vuotta total endocrine therapy (this may include tamoxifen or another AI in the first 2–3 years if exemestane is used in sequential setting). For higher-risk node-positive disease, extended therapy to 7–10 years is increasingly used. For metastatic disease, until progression or intolerable toxicity.

Will Xtane weaken my bones?

Yes — like all aromatase inhibitors. Some data suggest exemestane may produce slightly less bone-loss than anastrozole or letrozole because of its mild androgenic effect, but the clinical significance is debated and the safe assumption is that bone protection is needed. Mandatory baseline DEXA, repeat every 2 years. Calcium + vitamin D supplementation. Bisphosphonate (zoledronic acid IV every 6 months) or denosumab (60 mg SC every 6 months) if osteopenia.

How do I manage joint pain on Xtane?

Same approach as other AIs: regular exercise (yoga, walking, swimming), vitamin D supplementation, paracetamol or short NSAID courses, weight management. If intolerable, switching to anastrozole tai letrozole sometimes helps. Acupuncture has modest evidence in AI-induced arthralgia.

Can I use HRT or vaginal oestrogen on Xtane?

Generally not — even low-dose vaginal oestrogen produces measurable systemic absorption that can defeat AI therapy. First-line for vaginal symptoms: non-hormonal moisturisers (Replens, hyaluronic acid gels) and water-based lubricants. Specialists occasionally consider very low-dose vaginal oestriol on an individual risk-benefit basis.

Are there drug interactions I need to worry about?

The main one is strong CYP3A4 inducers (rifampicin, phenytoin, carbamazepine, St John's wort) which significantly reduce exemestane levels. If a CYP3A4 inducer is essential, the dose may be doubled to 50 mg/day under specialist guidance. Avoid St John's wort entirely. Otherwise, exemestane has relatively few drug interactions.

Lisää vaihtoehtoja syöpälääkkeissä

Luokiteltu MedsBase-tilausmäärän mukaan — mitä muut asiakkaat tässä kategoriassa valitsevat.

Vahvuus

25 mg

Määrä

30 Tablet/s, 60 Tablet/s, 90 Tablet/s, 180 Tablet/s, 360 Tablet/s, 720 Tablet/s

Arvostelut

Ei vielä arvosteluja

Lisää arvostelu
Xtane Xtane
Arvosana*
0/5
* Arvosana vaaditaan
* Vastaus vaaditaan
Arvostelusi
* Arvostelu vaaditaan
Nimi
* Nimi on pakollinen
Lisää kuvia tai video arvosteluusi

Kysymykset ja vastaukset

Esitä kysymys
Xtane Xtane
Kysymyksesi
* Kysymys on pakollinen
Nimi
* Nimi on pakollinen
Ei vielä kysymyksiä